Saransh Jain

Saransh Jain

Auto-generated profile, based on publicly available information

Saransh Jain

Department of Gastroenterology and Human Nutrition, All India Institute of Medical Sciences, New Delhi, India

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 July 2021 in Intestinal Research
Verified
Journal Article
Open access
PDF file
SSSanchit Sharma
Sanchit Sharma
VAVineet Ahuja
Vineet Ahuja
SKSaurabh Kedia
Saurabh Kedia
SASamagra Agarwal
Samagra Agarwal
NSNamrata Singh
Namrata Singh
VAVineet Ahuja
Vineet Ahuja
Background/Aims: Exclusive enteral nutrition (EEN), an established modality for pediatric Crohn’s disease (CD) is seldomly utilized in adults. The present study reports the outcome of EEN in adult CD patients at a tertiary care hospital in India.Methods: This was a retrospective analysis of CD patients who received EEN as a sole modality/adjunct to other treatment. The primary and secondary outcomes changed in Crohn’s Disease Activity Index (CDAI), and clinical response (decline in CDAI > 70), respectively, at 4 and 8 weeks. Subgroup analysis evaluated response across different phenotypes, EEN formulations and prior treatment. Linear mixed effect model was created to assess the predictors of EEN response.Results: Thirty-one CD patients received EEN over median duration of 4 weeks (range, 2–6 weeks). CDAI showed a significant improvement post EEN at 4 (baseline 290 [260–320] vs. 240 [180–280], P= 0.001) and 8 weeks (baseline 290 [260–320] vs. 186 [160–240], P= 0.001), respectively. The cumulative clinical response rates at 4 and 8 weeks were 37.3% and 80.4% respectively. The clinical response rates at 8 weeks across B1 (n = 4), B2 (n = 18) and B3 (n = 9) phenotypes were 50%, 78.8% and 100% respectively (log-rank test, P= 0.093). The response rates at 8 weeks with polymeric (n = 8) and semi-elemental diet (n = 23) were 75% and 82.6%% respectively (log-rank test, P= 0.49). Baseline CDAI (odds ratio, 1.008; 95% confidence interval, 1.002–1.017; P= 0.046) predicted response to EEN.Conclusions: EEN was effective in inducing clinical response across different phenotypes of CD. Baseline disease activity remained the most important predictor of clinical response to EEN.

2 April 2018 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
UAUmang Arora
Umang Arora
SKSaurabh Kedia
Saurabh Kedia
PGPrerna Garg
Prerna Garg
SBSawan Bopanna
Sawan Bopanna
SJSaransh Jain
Saransh Jain
VAVineet Ahuja
Vineet Ahuja

1 January 2017 in Intestinal Research
Verified
Journal Article
Open access
PDF file
AGAkshita Gupta
Akshita Gupta
SBSawan Bopanna
Sawan Bopanna
SKSaurabh Kedia
Saurabh Kedia
DYDawesh Prakash Yadav
Dawesh Prakash Yadav
SGSandeep Goyal
Sandeep Goyal
VAVineet Ahuja
Vineet Ahuja
Gupta A, et al. Intest Res. 2017 Jul;15(3):388-394. https://doi.org/10.5217/ir.2017.15.3.388

31 October 2021 in Intestinal Research
Verified
Journal Article
Open access
PDF file
SJSaransh Jain
Saransh Jain
DNDivya Namdeo
Divya Namdeo
PSPabitra Sahu
Pabitra Sahu
SKSaurabh Kedia
Saurabh Kedia
PSPeush Sahni
Peush Sahni
VAVineet Ahuja
Vineet Ahuja
Background/Aims: Predictors of short-term outcome of intravenous (IV) steroid therapy in acute severe ulcerative colitis (ASUC) have been well described, but the impact of cytomegalovirus (CMV) infection as a predictor of outcome remains debatable. We investigated the role of quantitative CMV polymerase chain reaction (PCR) as a predictor of short-term outcome in patients with ASUC.Methods: Consecutive patients with ASUC satisfying Truelove and Witts criteria hospitalized at All India Institute of Medical Sciences (AIIMS) from May 2016 to July 2019 were included; all received IV steroid. The primary outcome measure was steroid-failure defined as the need for rescue therapy (with ciclosporin or infliximab) or colectomy during admission. AIIMS’ index (ulcerative colitis index of severity > 6 at day 1+fecal calprotectin > 1,000 μg/g at day 3), with quantitative CMV PCR on biopsy samples obtained at initial sigmoidoscopy were correlated with the primary outcome.Results: Thirty of 76 patients (39%) failed IV corticosteroids and 12 (16%) underwent surgery. Patients with steroid failure had a significantly higher mucosal CMV DNA than responders (3,454 copies/mg [0–2,700,000] vs. 116 copies/mg [0–27,220]; P< 0.01). On multivariable analysis, mucosal CMV DNA load > 2,000 copies/mg (odds ratio [OR], 10.2; 95% confidence interval [CI], 2.6–39.7; P< 0.01) and AIIMS’ index (OR, 39.8; 95% CI, 4.4–364.4; P< 0.01) were independent predictors of steroid-failure and need for colectomy. The combination correctly predicted outcomes in 84% of patients with ASUC.Conclusions: High mucosal CMV DNA ( > 2,000 copies/mg) independently predicts failure of IV corticosteroids and short-term risk of colectomy and it has an additional value to the established markers of disease severity in patients with ASUC.

31 October 2023 in Intestinal Research
Verified
Journal Article
Open access
PDF file
PKPeeyush Kumar
Peeyush Kumar
SVSudheer Kumar Vuyyuru
Sudheer Kumar Vuyyuru
PDPrasenjit Das
Prasenjit Das
BKBhaskar Kante
Bhaskar Kante
MRMukesh Kumar Ranjan
Mukesh Kumar Ranjan
VAVineet Ahuja
Vineet Ahuja
Background/Aims: Evidence on predictors of primary nonresponse (PNR), and secondary loss of response (SLR) to anti-tumor necrosis factor (anti-TNF) agents in inflammatory bowel disease is scarce from Asia. We evaluated clinical/biochemical/molecular markers of PNR/SLR in ulcerative colitis (UC) and Crohn’s disease (CD).Methods: Inflammatory bowel disease patients treated with anti-TNF agents (January 2005–October 2020) were ambispectively included. Data concerning clinical and biochemical predictors was retrieved from a prospectively maintained database. Immunohistochemistry for expression of oncostatin M (OSM), OSM receptor (OSM-R), and interleukin-7 receptor (IL-7R) were done on pre anti-TNF initiation mucosal biopsies.Results: One-hundred eighty-six patients (118 CD, 68 UC: mean age, 34.1±13.7 years; median disease duration at anti-TNF initiation, 60 months; interquartile range, 28–100.5 months) were included. PNR was seen in 17% and 26.5% and SLR in 47% and 28% CD and UC patients, respectively. In CD, predictors of PNR were low albumin (P<0.001), postoperative recurrence (P=0.001) and high IL-7R expression (P<0.027) on univariate; and low albumin alone (hazard ratio [HR], 0.09; 95% confidence interval [CI], 0.03–0.28; P<0.001) on multivariate analysis respectively. Low albumin (HR, 0.31; 95% CI, 0.15–0.62; P=0.001) also predicted SLR. In UC, predictors of PNR were low albumin (P<0.001), and high C-reactive protein (P<0.001), OSM (P<0.04) and OSM-R (P=0.07) stromal expression on univariate; and low albumin alone (HR, 0.11; 95% CI, 0.03–0.39; P=0.001) on multivariate analysis respectively. Conclusions: Low serum albumin at baseline significantly predicted PNR in UC and PNR/SLR in CD patients. Mucosal markers of PNR were high stromal OSM/OSM-R in UC and high IL-7R in CD patients.

12 May 2023 in Indian Journal of Gastroenterology
Verified
Journal Article
Closed access
PDF file
SMSandeep Mundhra
Sandeep Mundhra
DTDavid Thomas
David Thomas
SJSaransh Jain
Saransh Jain
PSPabitra Sahu
Pabitra Sahu
SVSudheer Kumar Vuyyuru
Sudheer Kumar Vuyyuru
VAVineet Ahuja
Vineet Ahuja